NCT07731204

Brief Summary

Brief Summary The goal of this clinical trial is to learn if MUSIC CARE©, a music-based therapy tool, can improve the physical abilities of people with chronic low back pain (back pain that lasts more than 3 months). The main questions it aims to answer are: Does MUSIC CARE© help participants better perform their daily activities? Does MUSIC CARE© lower the fear of movement in participants? Does MUSIC CARE© help participants return to work? Why this study? Chronic low back pain is a leading cause of disability and absence from work. Physical rehabilitation is the recommended treatment. However, many participants develop a fear of movement. This fear slows down their recovery and limits the benefits of rehabilitation. MUSIC CARE© is a digital music tool. It uses specially designed music to help participants relax and feel less pain. Researchers believe that using MUSIC CARE© before rehabilitation sessions may help participants move more freely and recover better. How does the study work? Researchers will compare two groups of participants: Group 1: follows a standard rehabilitation program with MUSIC CARE© Group 2: follows a standard rehabilitation program without MUSIC CARE© This comparison will show whether MUSIC CARE© brings added benefits. Participants will: Take part in a rehabilitation program for 5 to 6 weeks Use MUSIC CARE© before each therapy session (Group 1 only). Complete questionnaires about their pain, fear of movement, and ability to perform daily activities. Be followed for 6 months after the program ends, including an assessment of their return to work. What could this study change? If results are positive, this study could confirm that MUSIC CARE© is a useful non-drug tool to support rehabilitation for people with chronic low back pain. It could help bring this approach into standard care programs, with no additional medication.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
34

participants targeted

Target at below P25 for not_applicable low-back-pain

Timeline
14mo left

Started Oct 2026

Typical duration for not_applicable low-back-pain

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 23, 2026

Completed
5 days until next milestone

First Posted

Study publicly available on registry

July 28, 2026

Completed
2 months until next milestone

Study Start

First participant enrolled

October 1, 2026

Expected
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2027

Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2027

Last Updated

July 28, 2026

Status Verified

July 1, 2026

Enrollment Period

1.2 years

First QC Date

July 23, 2026

Last Update Submit

July 23, 2026

Conditions

Keywords

Low Back PainChronic PainMusic TherapyPhysical Functional PerformanceKinesiophobiaFear of MovementRehabilitationExercise TherapyReturn to WorkNon-Pharmacological InterventionPatient Reported Outcome MeasuresFunctional Capacity

Outcome Measures

Primary Outcomes (1)

  • Change from Baseline in Functional Disability as Assessed by the EIFEL Questionnaire at End of Stay

    The EIFEL (Échelle d'Incapacité Fonctionnelle pour l'Évaluation des Lombalgies) is a validated 24-item self-administered questionnaire, adapted from the Roland-Morris Disability Questionnaire. Each item is answered yes (1) or no (0). The total score ranges from 0 to 24, where 0 indicates no functional disability and 24 indicates maximum functional disability. A higher score reflects greater impairment in daily life activities. A decrease in score indicates improvement in functional capacity. The minimal clinically important difference (MCID) is generally considered to be 2 to 3 points.

    Baseline (Day 1) and end of stay (Weeks 5 to 6)

Secondary Outcomes (9)

  • Change from Baseline in Functional Disability as Assessed by the EIFEL Questionnaire at 3 Months

    Baseline (Day 1) and 3 months post-discharge (Day 90 ± 7 days)

  • Change from Baseline in Functional Disability as Assessed by the EIFEL Questionnaire at 6 Months

    Baseline (Day 1) and 6 months post-discharge (Day 180 ± 7 days)

  • Change from Baseline in Physical Capacity and Functional Endurance as Assessed by the PILE Test at End of Stay

    Baseline (Day 1) and end of stay (Weeks 5 to 6)

  • Change from Baseline in Kinesiophobia as Assessed by the Tampa Scale of Kinesiophobia at End of Stay

    Baseline (Day 1) and end of stay (Weeks 5 to 6)

  • Change from Baseline in Kinesiophobia as Assessed by the Tampa Scale of Kinesiophobia at 3 Months

    Baseline (Day 1) and 3 months post-discharge (Day 90 ± 7 days)

  • +4 more secondary outcomes

Study Arms (2)

Interventional Group : MUSIC CARE© Combined with Standard Rehabilitation

EXPERIMENTAL

Participants receive a daily 20-minute receptive music session using the MUSIC CARE© device before each rehabilitation session throughout the 5-to-6-week day hospital stay. Seated comfortably in a dedicated room with headphones, participants listen to a personalized "U-sequence" (induction, deep relaxation, awakening phases). They then proceed to the standard multidisciplinary rehabilitation program, including physiotherapy, occupational therapy, adapted physical activity, and psychomotricity.

Device: Receptive Music Therapy

Control Group : Standard Rehabilitation Alone

NO INTERVENTION

Participants receive the standard multidisciplinary rehabilitation program for chronic low back pain over 5 to 6 weeks, including physiotherapy, occupational therapy, adapted physical activity, and psychomotricity. The program progresses from assessment and motor control work to trunk strengthening and preparation for professional reintegration. No music-based intervention is added.

Interventions

MUSIC CARE© is a Class 1 validated medical device delivering personalized receptive music therapy based on hypnoanalgesia principles. Each session follows a standardized "U-sequence" protocol comprising three phases: an induction phase with gradually decreasing tempo and orchestral complexity; a deep relaxation phase with slow tempo and minimal instrumentation; and a progressive awakening phase. Sessions are set at 20 minutes, administered daily before standard rehabilitation sessions throughout the 5-to-6-week day hospital stay. The sequence is pre-personalized by the investigator according to participant musical preferences collected at inclusion. The participant is seated alone in a dedicated room, wearing headphones connected to the MUSIC CARE© tablet.

Also known as: Receptive Music Intervention; Digital Music Therapy Tool
Interventional Group : MUSIC CARE© Combined with Standard Rehabilitation

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Diagnosed with chronic low back pain by a Physical Medicine and Rehabilitation (PMR) physician, defined as lumbar pain and/or pain radiating to the lower limb that affects daily and professional activities and has lasted more than 3 months
  • If surgery was performed, it must have been done at least 3 months before entering the study
  • Adult (18 years of age or older) admitted to the day hospital at Clinique Saint-Roch for a chronic low back pain rehabilitation program
  • Considered able to return to work, as assessed by the PMR physician during the pre-admission consultation, with no medical contraindication to resuming professional activity
  • Affiliated with a French social security scheme
  • Has given written informed consent to participate in the study

You may not qualify if:

  • Hearing impairment that would prevent the use of the MUSIC CARE© device
  • Medical contraindication to hydrotherapy (balneotherapy)
  • Symptomatic disc herniation
  • Vertebral fracture or history of recent vertebral fracture within the past 2 years
  • Unstable spondylolisthesis
  • Disc-vertebral infection (spondylodiscitis)
  • Inflammatory rheumatic disease such as ankylosing spondylitis (spondyloarthritis) or rheumatoid arthritis
  • Constitutional connective tissue disorder such as Ehlers-Danlos syndrome or Marfan syndrome
  • Severe, unstabilized, or decompensated psychiatric disorder, including psychotic disorders, acute-phase bipolar disorder, or severe major depressive episode
  • Central nervous system neurological disease such as multiple sclerosis, stroke, or Parkinson's disease
  • Peripheral neuropathy of the lower limbs
  • Unstabilized cardiovascular disease
  • Active cancer treatment or cancer diagnosis within the past 2 years
  • Surgery for a reason other than low back pain within the past 6 months
  • Currently retired (not in active employment)
  • +6 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Clinique Saint-Roch - LNA SANTE

Roncq, 59223, France

Location

MeSH Terms

Conditions

Low Back PainKinesiophobiaChronic Pain

Condition Hierarchy (Ancestors)

Back PainPainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsPhobic DisordersAnxiety DisordersMental Disorders

Study Officials

  • Mathieu Mr LEDUCQ

    LNA SANTE

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: Pilot Study - Single-center, prospective, randomized
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 23, 2026

First Posted

July 28, 2026

Study Start (Estimated)

October 1, 2026

Primary Completion (Estimated)

December 1, 2027

Study Completion (Estimated)

December 1, 2027

Last Updated

July 28, 2026

Record last verified: 2026-07

Locations